Onderneming Protagonist Therapeutics, Inc.
Aandelen
PTGX
US74366E1029
Biotechnologie & Medisch Onderzoek
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
28,93 USD | +1,58% | +2,05% | +26,17% |
Vakgebied
Aantal werknemers: 112
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Peptide-based Therapeutics
100,0
%
| 27 | 100,0 % | 60 | 100,0 % | +125,73% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 27 | 100,0 % | 60 | 100,0 % | +125,73% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 67 | 01-12-08 |
Asif Ali
DFI | Director of Finance/CFO | 50 | 18-04-22 |
Chief Tech/Sci/R&D Officer | - | 01-07-17 | |
Samuel Saks
CTO | Chief Tech/Sci/R&D Officer | 69 | 24-05-18 |
Arturo Molina
CTO | Chief Tech/Sci/R&D Officer | 65 | 07-11-22 |
Craig Ostroff
LAW | General Counsel | - | - |
Carena Spivey
HRO | Human Resources Officer | - | - |
Suneel Gupta
PRN | Corporate Officer/Principal | 66 | 17-01-19 |
Ashok Bhandari
PRN | Corporate Officer/Principal | - | 01-01-17 |
Carter J. King
PRN | Corporate Officer/Principal | 52 | 01-09-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Lewis Williams
BRD | Director/Board Member | 74 | 08-06-17 |
Harold Selick
CHM | Chairman | 69 | 01-02-09 |
Daniel Swisher
BRD | Director/Board Member | 61 | 26-10-23 |
Dinesh Patel
CEO | Chief Executive Officer | 67 | 01-12-08 |
Sarah O'Dowd
BRD | Director/Board Member | 74 | 12-08-20 |
William Waddill
BRD | Director/Board Member | 66 | 01-07-16 |
Bryan Giraudo
BRD | Director/Board Member | 48 | 16-05-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 58 274 998 | 56 809 066 ( 97,48 %) | 0 | 97,48 % |
Bedrijfsgegevens
Protagonist Therapeutics, Inc.
7707 Gateway Boulevard Suite 140
94560-1160, Newark
+
http://www.protagonist-inc.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+26,17% | 1,69 mld. | |
+9,30% | 46,03 mld. | |
+52,73% | 44,55 mld. | |
+7,15% | 40,8 mld. | |
-8,78% | 28,25 mld. | |
+18,68% | 27,71 mld. | |
-21,92% | 18,82 mld. | |
+14,62% | 13,91 mld. | |
+31,85% | 12,43 mld. | |
-8,77% | 11,06 mld. |
- Beurs
- Aandelen
- Aandeel Protagonist Therapeutics, Inc. - Nasdaq
- Onderneming Protagonist Therapeutics, Inc.